Lv5
1106 积分 2025-01-21 加入
Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer
1天前
待确认
VEGF-targeted therapy: mechanisms of anti-tumour activity
1天前
已完结
Current Treatment Landscape for Third- or Later-Line Therapy in Metastatic Colorectal Cancer
1天前
待确认
Alcohol drinking and colorectal cancer risk: an overall and dose–response meta-analysis of published studies
1天前
已完结
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
1天前
已完结
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
1天前
已完结
Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?
1天前
待确认
Sorafenib plus Doxorubicin versus Sorafenib alone for advanced hepatocellular carcinoma (Soradox trial): final results of a prospective, randomized, open-label, multicenter phase IIB trial
1天前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
1天前
已完结
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial
1天前
已完结
皖公网安备34019202002308
